Pyxis Oncology (PYXS) Insider Trading & Ownership → How Biden has already won 2024 (From Porter & Company) (Ad) Free PYXS Stock Alerts $4.15 -0.02 (-0.48%) (As of 05/17/2024 ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Pyxis Oncology (NASDAQ:PYXS) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage8.40%Number OfInsiders Buying(Last 12 Months)2Amount OfInsider Buying(Last 12 Months)$58,503.10Number OfInsiders Selling(Last 12 Months)1Amount OfInsider Selling(Last 12 Months)$70,146.10 Get PYXS Insider Trade Alerts Want to know when executives and insiders are buying or selling Pyxis Oncology stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address PYXS Insider Buying and Selling by Quarter Ad Weiss Ratings[URGENT] DO NOT Touch These AI Stocks!Artificial intelligence stocks are carrying the market. One of them, Nvidia, recently became the seventh company ever to hit a $1 trillion market cap. But is this AI rally over?Click here for our #1 AI Stock for 2024 and Beyond Pyxis Oncology Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails9/27/2023Jitendra WadhaneCAOBuy2,500$1.87$4,675.00 9/27/2023Pamela Ann ConnealyCFOBuy6,426$1.85$11,888.10 9/25/2023Jitendra WadhaneCAOBuy5,000$1.77$8,850.00 9/25/2023Pamela Ann ConnealyCFOBuy12,000$1.67$20,040.00 9/22/2023Jitendra WadhaneCAOBuy2,500$1.74$4,350.00 9/22/2023Pamela Ann ConnealyCFOBuy5,000$1.74$8,700.00 9/18/2023Lara SullivanCEOSell8,541$2.10$17,936.10 9/13/2023Lara SullivanCEOSell3,000$2.27$6,810.00 9/11/2023Lara SullivanCEOSell20,000$2.27$45,400.00 (Data available from 1/1/2013 forward) PYXS Insider Trading Activity - Frequently Asked Questions Who is on Pyxis Oncology's Insider Roster? The list of insiders at Pyxis Oncology includes Darren S Cline, Jitendra Wadhane, Lara Sullivan, Mark Chin, Pamela Ann Connealy, Pfizer Inc, and Thomas Civik. Learn more on insiders at PYXS. What percentage of Pyxis Oncology stock is owned by insiders? 8.40% of Pyxis Oncology stock is owned by insiders. Learn more on PYXS's insider holdings. Which Pyxis Oncology insiders have been buying company stock? The following insiders have purchased PYXS shares in the last 24 months: Jitendra Wadhane ($17,875.00), Pamela Ann Connealy ($40,628.10), and Pfizer Inc ($4,999,999.44). How much insider buying is happening at Pyxis Oncology? Insiders have purchased a total of 1,845,020 PYXS shares in the last 24 months for a total of $5,058,502.54 bought. Which Pyxis Oncology insiders have been selling company stock? The following insider sold PYXS shares in the last 24 months: Lara Sullivan ($70,146.10). How much insider selling is happening at Pyxis Oncology? Insiders have sold a total of 31,541 Pyxis Oncology shares in the last 24 months for a total of $70,146.10 sold. More Insider Trading Tools from MarketBeat Related Companies: 2seventy bio Insider Transactions Design Therapeutics Insider Transactions Werewolf Therapeutics Insider Transactions Aldeyra Therapeutics Insider Transactions Nektar Therapeutics Insider Transactions 23andMe Insider Transactions Foghorn Therapeutics Insider Transactions Veru Insider Transactions Enanta Pharmaceuticals Insider Transactions CytomX Therapeutics Insider Transactions Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: 4 Small-Cap Energy Stocks Insiders are Buying 3 Penny Stocks That Insiders Are BuyingThe 3 Hottest Insiders Buys This Month 3 Companies Buying Back Cheap Stock LatelyPagaya Technologies: An AI Fintech That Insiders Are Buying This page (NASDAQ:PYXS) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaMissed NVDA? Buy this AI stock NOWChaikin AnalyticsUrgent Nvidia WarningAltimetryCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingMost important medical advance in 100 yearsThe Oxford ClubNext President (Not Trump. Not Biden.)The Freeport SocietyCrypto Pioneer Says: “The last crypto bull market has begun.”InvestorPlaceProtect Your Bank Account Before It’s Too LateWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pyxis Oncology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.